Upcoming event
UROwebinar: Role of liquid biopsy in identifying mCRPC patients harbouring specific aberrations - A focus on AR-LBD mutations
Back

Tag: ProtecT trial

Active monitoring, surgery, and radiotherapy for cribriform-positive and cribriform-negative prostate cancer: A secondary analysis of the PROTECT randomised clinical trial

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received